Free Trial

Verici Dx (VRCI) Competitors

Verici Dx logo
GBX 3.38 0.00 (0.00%)
(As of 11/21/2024 ET)

VRCI vs. YGEN, ABDX, GDR, GENI, PRM, LLAI, IDHC, DMTR, LLA, and DXRX

Should you be buying Verici Dx stock or one of its competitors? The main competitors of Verici Dx include Yourgene Health (YGEN), Abingdon Health (ABDX), genedrive (GDR), GENinCode (GENI), Proteome Sciences (PRM), LungLife AI (LLAI), Integrated Diagnostics (IDHC), Deepmatter Group (DMTR), LLA.L,0P0001T9GN,0 (LLA), and Diaceutics (DXRX). These companies are all part of the "diagnostics & research" industry.

Verici Dx vs.

Verici Dx (LON:VRCI) and Yourgene Health (LON:YGEN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment.

Verici Dx has higher earnings, but lower revenue than Yourgene Health. Verici Dx is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Verici Dx£4.33M1.89-£4.81M-£0.02-168.75
Yourgene Health£29.67M0.55-£8.17M-£0.01-51.50

Yourgene Health has a net margin of -27.55% compared to Verici Dx's net margin of -110.99%. Yourgene Health's return on equity of -27.06% beat Verici Dx's return on equity.

Company Net Margins Return on Equity Return on Assets
Verici Dx-110.99% -58.12% -26.14%
Yourgene Health -27.55%-27.06%-6.71%

Verici Dx has a beta of 1.59, meaning that its share price is 59% more volatile than the S&P 500. Comparatively, Yourgene Health has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500.

51.9% of Verici Dx shares are held by institutional investors. Comparatively, 23.3% of Yourgene Health shares are held by institutional investors. 17.1% of Verici Dx shares are held by company insiders. Comparatively, 64.4% of Yourgene Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Yourgene Health received 17 more outperform votes than Verici Dx when rated by MarketBeat users.

CompanyUnderperformOutperform
Verici DxN/AN/A
Yourgene HealthOutperform Votes
17
53.13%
Underperform Votes
15
46.88%

In the previous week, Verici Dx's average media sentiment score of 0.00 equaled Yourgene Health'saverage media sentiment score.

Company Overall Sentiment
Verici Dx Neutral
Yourgene Health Neutral

Summary

Yourgene Health beats Verici Dx on 8 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VRCI vs. The Competition

MetricVerici DxDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£8.19M£26.21M£5.09B£1.42B
Dividend YieldN/A5.44%5.04%11.56%
P/E Ratio-165.001.91101.481,569.60
Price / Sales1.892,191.961,207.98219,445.82
Price / Cash1.319.9539.7133.65
Price / Book0.842.346.932.81
Net Income-£4.81M£45.44M£118.81M£157.07M
7 Day Performance18.42%2.09%-1.39%-0.63%
1 Month Performance-15.63%-3.44%-3.29%3.20%
1 Year Performance-65.38%7.42%32.29%97.44%

Verici Dx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRCI
Verici Dx
N/AGBX 3.38
flat
N/A-65.7%£8.19M£4.33M-165.0019
YGEN
Yourgene Health
N/AGBX 0.52
flat
N/A+0.0%£16.43M£29.67M-51.50253
ABDX
Abingdon Health
N/AGBX 7.25
flat
N/A-32.5%£13.74M£6.13M-899.0084News Coverage
GDR
genedrive
N/AGBX 2.45
+2.1%
N/A-66.9%£13.31M£49,000.00-60.0043
GENI
GENinCode
N/AGBX 4.18
+0.7%
N/A-44.0%£7.40M£2.60M-83.602,300Gap Down
PRM
Proteome Sciences
N/AGBX 2.30
-16.4%
N/A-54.2%£6.79M£4.04M-230.00240Gap Down
LLAI
LungLife AI
N/AGBX 8.75
flat
N/A-90.7%£2.68M£98,566.00-67.3115
IDHC
Integrated Diagnostics
N/AGBX 0.38
-2.6%
N/A+18.2%£2.21M£4.75B12.336,692Gap Down
DMTR
Deepmatter Group
N/AGBX 0.03
+22.2%
N/A+0.0%£1.33M£1.04M-0.11N/AGap Down
LLA
LLA.L,0P0001T9GN,0
N/AGBX 15
flat
N/AN/A£0.00N/A-125.0015High Trading Volume
DXRX
Diaceutics
N/AGBX 117.10
-1.2%
GBX 160
+36.6%
+32.6%£98.91M£26.09M-3,933.33151

Related Companies and Tools


This page (LON:VRCI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners